Californium-252 is a neutron emitter with a high specific
activity, making it useful in a variety of applications, the most
spectacular of which is in brachytherapy for cancer patients.
Radiation oncology has exhausted nearly every option for treating
radioresistant tumors by photon brachytherapy, and therefore new types
of radiation need to be studied to improve the curability of cancer.
Audience: Californium brachytherapy is used in only a few
radiation therapy centers in the world, so the book will be highly
instructive for radiation oncologists, medical physicists and
radiobiologists. The nuclear techniques used in clinical applications
may also interest nuclear physicists and engineers.
Edited by:
J.G. Wierzbicki Imprint: Kluwer Academic Publishers Country of Publication: United States Edition: 1997 ed. Volume: 29 Dimensions:
Height: 235mm,
Width: 155mm,
Spine: 230mm
Weight: 706g ISBN:9780792345435 ISBN 10: 0792345436 Series:NATO Science Partnership Subseries: 3 Pages: 300 Publication Date:30 April 1997 Audience:
Professional and scholarly
,
Undergraduate
Format:Hardback Publisher's Status: Active
Yosh Maruyama — Father of Neutron Brachytherapy.- I. Production and Physical Properties of Californium Sources.- Californium-252 Production and Neutron Source Fabrication.- Physics and Dosimetry of Clinical 252Cf Sources.- II. Brachytherapy of Gynaecological Tumors.- Ta?ev of Cf-252 and Ra-226 Radiation Doses and the Reoxygenation and Regression of Cervix Uteri Tumor. Part I: Clinical Experimental Study.- The Relationship of Cf-252 and Ra-226 Radiation Doses and the Reoxygenation and Regression of Cervix Uteri Tumor. Part II: Preliminary Results in Advanced Cervical Carcinoma.- Californium-252 and Hypoxyradiotherapy in Treatment of Advanced Carcinoma of the Cervix Uteri.- Results of Mixed Radiation Therapy of Endometrial Cancer using Neutron Gamma-Therapy.- Preoperative Intracavitary Neutron Therapy Carcinoma of Endometrial and Cervix.- The Results of Treatment of Patients with Endometrial Cancer and Carcinoma Cervix using Californium-252 HDR.- Clinical Experience of Neutron Brachytherapy for Patients with Cervix Carcinoma.- III. Brachytherapy of Head and Neck Tumors.- Radiation Injuries of Oral Cavity and Oropharynx after Interstitial Neutron Brachytherapy and Gamma-Therapy.- Brachytherapy with Californium-252 for Head and Neck Tumors.- Immunoendocrine Homeostasis State in Patients with Cancer of the Buccal Mucosa after Interstitial Therapy with Californium-252.- IV. Brachytherapy of Rectal Tumors and Sarcomas.- Intracavitary Neutron Therapy for Malignant Rectal Tumors using High Cf-252 Sources.- Preoperative Radiotherapy in the Treatment of Rectal Carcinoma.- Californium-252 in the Treatment of Soft Tissue Sarcoma.- V. Dosimetry, Radiobiology and Treatment Planning of Mixed Neutron-Photon Radiation.- Treatment Planning for Interstitial and Intracavitary Cf-252Neutron Brachytherapy.- Dosimetry and Treatment Planning in High Dose Rate Cf-252 Brachytherapy.- To the Problem on Selection of the Target in Brachytherapy with Cf-252.- Factors Influencing the Efficiency of Cf-252 Brachytherapy: Clinical and Technological Aspects.- Biological Effects of Gamma-Neutron Radiation Cf-252 or Fission Neutron from the BR-10 Reactor on Tumor and Normal Cells and Tissues.- Cf-252 Brachytherapy in Cervical Cancer: Monte Carlo Studies of the Effect of Tissue Heterogeneity.- VI. Source Design and Delivery.- Automatic Afterloading Device for Neutron Brachytherapy (ANET-BA).- Small Accelerators — An Alternative Source of Neutrons for Brachytherapy.- The IEC as a Complementary Neutron Source to Cf-252.